Skip to content

A randomized controlled study of a precise and quantitative nursing scheme for rapid lung rehabilitation in elderly patients (>= 70 years old) with lung cancer

A randomized controlled study of a precise and quantitative nursing scheme for rapid lung rehabilitation in elderly patients (>= 70 years old) with lung cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042916
Enrollment
Unknown
Registered
2021-01-31
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

control group:routine nursing scheme
study group:Precise quantitative nursing scheme

Sponsors

Shanghai pulmonary hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Aged >= 70 years; (2) chest CT / PETCT results of selected patients should meet the following conditions: A. suspected non-small cell lung cancer; B. tumor is suitable for lobectomy, resection can meet the requirements of free margin; (3) intraoperative criteria: A. single port thoracoscopic lobectomy can be successfully completed without obvious dense adhesion or vascular variation; B. non small cell lung cancer confirmed by frozen pathology (4) general inclusion criteria: A. obtaining informed consent signed by the patient or his legal representative; B. functional reserve of various organs to meet lobectomy; C. completing 4-year mortality prediction index scale; D. completing comprehensive geriatric assessment (CGA).

Exclusion criteria

Exclusion criteria: (1) Unable to comply with the study protocol or procedure; (2) previous thoracic surgery history; (3) any unstable systemic diseases, including uncontrolled hypertension, unstable angina pectoris, congestive heart failure (>= NYHA class II), myocardial infarction within half a year; Severe arrhythmia, liver, kidney or metabolic disease requiring drug treatment; (4) uncontrollable infection; (5) mental illness; (6) other conditions considered unsuitable by researchers.

Design outcomes

Primary

MeasureTime frame
perioperative tube length;

Secondary

MeasureTime frame
postoperative FEV1 value/preoperative FEV1 value;

Countries

China

Contacts

Public ContactBei Chen

Shanghai Pulmonary Hospital

479625391@qq.com+86 13917517283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026